November 2, 2004 Scientists Find ‘Holy Grail’ of Hearing Research CHICAGO—Northwestern University neuroscientists and colleagues have identified a protein long considered to be the missing link in hearing research, a finding that may eventually lead to gene therapies for deafness. In the online version of the journal Nature, Jaime Garcia-Añoveros, PhD, Anne Duggan, PhD, and[…]
November 9, 2004 Over-the-Counter Drugs Could Save $4.75 Billion Annually Using nonprescription, or over-the-counter (OTC), medications to treat common upper respiratory infections could save $4.75 billion a year, according to a new study conducted by researchers from Northwestern University. The study, which was sponsored by the Consumer Healthcare Products Association and was presented on October[…]
November 16, 2004 Stable Weight Reduces Heart Risk CHICAGO—Gaining 15 pounds or more over several years is the major contributor to progression of risk factors for heart disease and development of metabolic syndrome, while maintaining a stable weight—even in individuals considered obese—significantly reduces those risks, according to a study led by a Northwestern University researcher.[…]
Study Assesses Effect of Tomato Oil on Precancerous Prostate Changes Lycopene, an antioxidant commonly found in tomatoes and tomato-based products, is perceived to reduce the risk of developing prostate cancer. A new study at Northwestern University seeks to determine whether natural tomato oil with a high concentration of lycopene may reverse or delay progression of[…]
Stem Cell Biologist John Kessler Argues for Change in Government Policies The controversy over stem cell research continues to grab headlines, especially in this presidential election year. For scientists, the field shows great promise for developing treatments and cures for a wide variety of diseases and conditions. For the general public, the field is often[…]
Young Women with Low Risk Have Lower Death Rate By Elizabeth Crown Young women at low risk for coronary heart disease and cardiovascular diseases (CVD) have lower long-term death rates from these diseases and all other causes compared with those with higher risk levels, according to an article in the Oct. 6 issue of the[…]
October 12, 2004 Nobel Winner is Northwestern Researcher CHICAGO—Northwestern University’s Feinberg School of Medicine has a connection to the 2004 Nobel Prize in Chemistry. Nobel laureate Aaron Ciechanover, PhD, who with two other scientists discovered how a protein called ubiquitin within cells targets other proteins to be discarded, is in the second year of a[…]
October 19, 2004 $2.1 Million Grant Funds Parkinson’s Research CHICAGO—Northwestern University has received a three-year, $2.1 million award from the Picower Foundation to study the molecular and cellular mechanisms of Parkinson’s disease. D. James Surmeier, PhD, Nathan Smith Davis Professor and chair of physiology at Northwestern University’s Feinberg School of Medicine, is the principal investigator[…]
Scientist Receives $3.5 Million to Study Genetics of ALS Teepu Siddique, MD, Abbott Labs Duane and Susan Burnham Research Professor at the Feinberg School, has received a $3.5 million grant from the National Institute of Neurological Disorders and Stroke to study the genetics of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS[…]
October 5, 2004 System Helps Curb Severe Anemia CHICAGO—Cooperation among international adverse event reporting agencies has led to an 83 percent decline in a rare, potentially life-threatening form of anemia associated with recombinant human erythropoietin (epoetin), a widely used product for anemia that occurs among cancer patients or persons undergoing dialysis. Epoetin is the most[…]